In 2022, infections were linked to 2.5 million new cancer diagnoses. The primary bacterium involved in carcinogenic ...

Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...

Once considered a disease of older adults, colorectal cancer is now on the rise among young people in at least 27 countries.

US FDA grants Breakthrough Device Designation to Mursla Bio’s EvoLiver test: Cambridge, UK Friday, April 25, 2025, 17:00 Hrs [IST] Mursla Bio, a leader in Extracellular Vesicle ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

MemorialCare Saddleback Medical Center has launched a new Skin Cancer Program and specialized Melanoma Clinic to provide ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

Linda Jackson, who is living with stage 4 metastatic cancer, is running this year's London Marathon alongside her son David ...

Cervical cancer is largely preventable, yet continues to pose a significant threat, especially to young Indian women. The time to act is now—and it begins with catching them young., Health News - Time ...

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ... the trial's two primary endpoints. Merck said there were ...